Scientific Director
Johnson and Johnson
Spring House, Pennsylvania
Dr. Prathap Nagaraja Shastri is serving as the Scientific Director in DMPK at Janssen Research and Development, LLC at Spring House, PA. His team consists of a core group of DMPK project leaders and PK/PD scientists serving on discovery and compound development teams from pre-portfolio through Phase 1 studies, enabling E2E DMPK deliverables supporting biologics portfolio across therapeutic areas. Previously, he served as the functional lead for DMPK and toxicology at Ambrx, La Jolla, California, and as the Study Director/Research Scientist at Charles River and Seventh Wave Laboratories within the DMPK group, responsible for PK/TK analysis, strategic consulting on lead candidate selection and human equivalent dose projections and served as the study director for in-vitro/in-vivo DMPK studies. Dr. Shastri holds PhD in Pharmaceutical Sciences from Mercer University, Atlanta, and Bachelors in Pharmacy from Rajiv Gandhi University, India.
Disclosure information not submitted.
Monday, October 17, 2022
12:30 PM – 1:30 PM ET
Monday, October 17, 2022
1:30 PM – 2:30 PM ET
Monday, October 17, 2022
5:00 PM – 6:00 PM ET
Tuesday, October 18, 2022
8:30 AM – 9:00 AM ET